303 related articles for article (PubMed ID: 23773018)
1. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
[TBL] [Abstract][Full Text] [Related]
2. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
3. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of leucocyte antibodies in non-transfused male and female platelet apheresis donors.
Simtong P; Sudwilai Y; Cheunta S; Leelayuwat C; Romphruk AV
Transfus Med; 2021 Jun; 31(3):186-192. PubMed ID: 33949000
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
[TBL] [Abstract][Full Text] [Related]
6. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
7. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
[TBL] [Abstract][Full Text] [Related]
8. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
9. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
10. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
11. Analysis of a high-throughput HLA antibody screening assay for use with platelet donors.
Fadeyi E; Adams S; Peterson B; Hackett J; Byrne P; Klein HG; Marincola FM; Leitman SF; Stroncek DF
Transfusion; 2008 Jun; 48(6):1174-9. PubMed ID: 18422853
[TBL] [Abstract][Full Text] [Related]
12. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
[TBL] [Abstract][Full Text] [Related]
13. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
[TBL] [Abstract][Full Text] [Related]
14. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
15. [HLA and transfusion: new approaches with Luminex™ technology].
Giannoli C; Nguyen TK; Dubois V
Transfus Clin Biol; 2011 Apr; 18(2):218-23. PubMed ID: 21397543
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of HLA sensitization in female apheresis donors.
Densmore TL; Goodnough LT; Ali S; Dynis M; Chaplin H
Transfusion; 1999 Jan; 39(1):103-6. PubMed ID: 9920173
[TBL] [Abstract][Full Text] [Related]
17. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
19. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
20. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.
Quillen K; Medrano C; Adams S; Peterson B; Hackett J; Leitman SF; Klein HG; Stroncek DF
Transfusion; 2011 Mar; 51(3):504-10. PubMed ID: 20849407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
